Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Derisomaltose in Stabilised Acute Heart Failure
NCT05971732Phase 4Unknown
- Sponsor
- China-Japan Friendship Hospital
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by China-Japan Friendship Hospital. Status: unknown.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05971732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05971732.